slotkoers
Korea S.E.
00:00:00 12-06-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
46.400
KRW
|
-5,02%
|
|
+25,58%
|
+303,48%
|
Fiscaal tijdperk: december |
2023
|
---|
Marktkapitalisatie
1 |
130.376
|
Bedrijfswaarde
1 |
131.714
|
K/w-verhouding
|
-16,7
x
|
Dividendrendement
|
-
|
Marktkapitalisatie/omzet
|
9,95
x
|
Bedrijfswaarde/omzet
|
10
x
|
Bedrijfswaarde/EBITDA
|
-29,7
x
|
Bedrijfswaarde/FCF
|
-16,5
x
|
FCF Yield
|
-6,05%
|
Price to Book
|
18,8
x
|
Aantal aandelen (in duizenden)
|
11.337
|
Referentieprijs
2 |
11.500
|
Datum van publicatie
|
21-03-24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
3.160
|
5.014
|
5.319
|
8.868
|
12.113
|
13.108
|
EBITDA
1 |
-5.101
|
-7.807
|
-7.084
|
-3.180
|
-2.235
|
-4.436
|
Bedrijfsresultaat (EBIT)
1 |
-6.013
|
-9.075
|
-8.433
|
-4.628
|
-3.752
|
-5.989
|
Operationele Marge
|
-190,27%
|
-180,98%
|
-158,54%
|
-52,19%
|
-30,98%
|
-45,69%
|
Resultaat voor belastingen (EBT)
1 |
-10.843
|
-9.015
|
-8.594
|
-5.249
|
-5.210
|
-6.337
|
Nettowinst (verlies)
1 |
-10.200
|
-8.098
|
-7.747
|
-5.667
|
-6.327
|
-7.524
|
Nettomarge
|
-322,72%
|
-161,51%
|
-145,64%
|
-63,9%
|
-52,23%
|
-57,39%
|
WPA
2 |
-5.308
|
-3.330
|
-766,4
|
-558,2
|
-619,1
|
-688,2
|
Free Cash Flow
1 |
-5.371
|
-3.921
|
-3.832
|
-3.057
|
-9.322
|
-7.972
|
FCF-marge
|
-169,95%
|
-78,2%
|
-72,04%
|
-34,48%
|
-76,96%
|
-60,82%
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
01-04-19
|
30-03-20
|
31-03-21
|
31-03-22
|
23-03-23
|
21-03-24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
6.377
|
1.337
|
Nettokaspositie
1 |
12.843
|
11.074
|
6.846
|
6.073
|
-
|
-
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-2,854
x
|
-0,3015
x
|
Free Cash Flow
1 |
-5.371
|
-3.921
|
-3.832
|
-3.057
|
-9.322
|
-7.972
|
ROE (netto-inkomsten/eigen vermogen)
|
-293%
|
-64,4%
|
-98%
|
-121%
|
-195%
|
-97,1%
|
ROA (netto-inkomsten/totale activa)
|
-19,2%
|
-25%
|
-26,1%
|
-16,1%
|
-11,1%
|
-13,3%
|
Totale activa
1 |
53.248
|
32.331
|
29.654
|
35.130
|
56.863
|
56.585
|
Nettoactief per aandeel
2 |
8.079
|
5.195
|
573,0
|
246,0
|
-370,0
|
611,0
|
Cashflow per aandeel
2 |
1.388
|
1.369
|
905,0
|
600,0
|
398,0
|
124,0
|
Capex
1 |
1.971
|
553
|
183
|
474
|
9.295
|
1.847
|
Capex/omzet
|
62,37%
|
11,04%
|
3,43%
|
5,35%
|
76,74%
|
14,09%
|
Datum van publicatie
|
01-04-19
|
30-03-20
|
31-03-21
|
31-03-22
|
23-03-23
|
21-03-24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| +303,48% | 388 mln. | | +0,46% | 91,38 mld. | | -2,37% | 38,68 mld. | | +70,79% | 27,84 mld. | | -12,31% | 16,05 mld. | | -4,54% | 13,48 mld. | | -10,83% | 11,73 mld. | | +180,20% | 10,74 mld. | | -48,60% | 10,39 mld. | | +1,20% | 8,94 mld. |
Biofarmaceutica
|